Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$248.14
-11.55-4.45%
À la fermeture: -
$248.14
0.000.00%
Après les heures de négociation: 4:00 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
Labcorp Holdings Inc a un objectif de cours consensus de $278.22, basé sur les évaluations des 25 analystes. Le plus élevé est de $320 attribué par UBS le octobre 29, 2025, et le plus bas est de $230 attribué par Deutsche Bank le août 2, 2024. Les 3 dernières évaluations d'analystes ont été publiées par UBS, UBS et Mizuho le octobre 29, 2025, octobre 17, 2025 et octobre 17, 2025. Avec un objectif de cours moyen de $321.67 entre UBS, UBS et Mizuho, il y a une variation implicite de 29.63% upside pour Labcorp Holdings Inc à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
UBS
Mizuho
Evercore ISI Group
Barclays
Truist Securities
1calculé à partir des notes des analystes
Notes d'analystes pour Labcorp Hldgs
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/29/2025 | 28.96% | UBS | $325 → $320 | Maintains | Buy | |||
10/17/2025 | 30.97% | UBS | $305 → $325 | Maintains | Buy | |||
10/17/2025 | 28.96% | Mizuho | $285 → $320 | Maintains | Outperform | |||
10/03/2025 | 22.91% | Evercore ISI Group | $300 → $305 | Maintains | Outperform | |||
10/02/2025 | 16.87% | Barclays | $275 → $290 | Maintains | Equal-Weight | |||
07/25/2025 | 24.93% | Truist Securities | $290 → $310 | Maintains | Buy | |||
07/25/2025 | 22.91% | UBS | $282 → $305 | Maintains | Buy | |||
07/25/2025 | 20.9% | Evercore ISI Group | $285 → $300 | Maintains | Outperform | |||
07/25/2025 | 23.32% | Morgan Stanley | $283 → $306 | Maintains | Overweight | |||
07/25/2025 | 21.71% | Baird | $290 → $302 | Maintains | Outperform | |||
07/18/2025 | 13.65% | UBS | $284 → $282 | Maintains | Buy | |||
07/09/2025 | 14.85% | Evercore ISI Group | $260 → $285 | Maintains | Outperform | |||
06/25/2025 | 10.82% | Barclays | $250 → $275 | Maintains | Equal-Weight | |||
06/11/2025 | 14.05% | Morgan Stanley | $270 → $283 | Maintains | Overweight | |||
05/12/2025 | 16.87% | Truist Securities | $274 → $290 | Maintains | Buy | |||
05/06/2025 | 12.84% | Piper Sandler | $260 → $280 | Maintains | Neutral | |||
04/30/2025 | 0.75% | Barclays | $240 → $250 | Maintains | Equal-Weight | |||
04/30/2025 | 7.6% | Baird | $253 → $267 | Maintains | Outperform | |||
04/11/2025 | 10.42% | Truist Securities | $285 → $274 | Maintains | Buy | |||
04/10/2025 | -3.28% | Barclays | $260 → $240 | Maintains | Equal-Weight | |||
04/02/2025 | 11.23% | Redburn Atlantic | → $276 | Initiates | → Buy | |||
03/04/2025 | 20.9% | Citigroup | $250 → $300 | Upgrade | Neutral → Buy | |||
02/10/2025 | 4.78% | Piper Sandler | $240 → $260 | Maintains | Neutral | |||
02/07/2025 | 4.78% | Barclays | $271 → $260 | Maintains | Equal-Weight | |||
02/06/2025 | 16.87% | Jefferies | $275 → $290 | Maintains | Buy | |||
02/03/2025 | 9.21% | Barclays | $249 → $271 | Maintains | Equal-Weight | |||
01/28/2025 | 15.26% | UBS | $293 → $286 | Maintains | Buy | |||
01/07/2025 | 6.79% | Evercore ISI Group | $260 → $265 | Upgrade | In-Line → Outperform | |||
12/17/2024 | 8.81% | Morgan Stanley | $260 → $270 | Maintains | Overweight | |||
12/13/2024 | 9.21% | B of A Securities | $262 → $271 | Maintains | Buy | |||
12/10/2024 | 10.82% | Jefferies | → $275 | Assumes | → Buy | |||
10/30/2024 | — | HSBC | — | Upgrade | Hold → Buy | |||
10/28/2024 | -3.28% | Piper Sandler | $235 → $240 | Maintains | Neutral | |||
10/25/2024 | 18.08% | UBS | $270 → $293 | Maintains | Buy | |||
10/25/2024 | 0.35% | Barclays | $234 → $249 | Maintains | Equal-Weight | |||
10/25/2024 | 16.47% | Baird | $282 → $289 | Maintains | Outperform | |||
10/16/2024 | -5.7% | Barclays | $249 → $234 | Maintains | Equal-Weight | |||
10/01/2024 | -5.3% | Piper Sandler | → $235 | Initiates | → Neutral | |||
09/24/2024 | -3.28% | Evercore ISI Group | $250 → $240 | Maintains | In-Line | |||
09/23/2024 | 6.79% | Jefferies | $245 → $265 | Maintains | Buy | |||
09/20/2024 | 13.65% | Baird | $278 → $282 | Maintains | Outperform | |||
08/05/2024 | 4.78% | B of A Securities | $240 → $260 | Maintains | Buy | |||
08/02/2024 | -7.31% | Deutsche Bank | $220 → $230 | Maintains | Hold | |||
08/02/2024 | 8.81% | UBS | $260 → $270 | Maintains | Buy | |||
08/02/2024 | 0.35% | Barclays | $213 → $249 | Maintains | Equal-Weight | |||
08/02/2024 | 11.63% | Baird | $261 → $277 | Maintains | Outperform | |||
08/02/2024 | 10.82% | Truist Securities | $255 → $275 | Maintains | Buy | |||
07/09/2024 | -13.36% | Evercore ISI Group | $210 → $215 | Maintains | In-Line | |||
07/08/2024 | 5.18% | Baird | $258 → $261 | Maintains | Outperform | |||
06/13/2024 | 3.97% | Baird | $256 → $258 | Maintains | Outperform | |||
05/30/2024 | -2.07% | JP Morgan | $261 → $243 | Maintains | Overweight | |||
04/26/2024 | 2.76% | Truist Securities | $270 → $255 | Maintains | Buy | |||
04/26/2024 | -14.16% | Barclays | $234 → $213 | Maintains | Equal-Weight | |||
04/26/2024 | -1.67% | Baird | $255 → $244 | Maintains | Outperform | |||
03/25/2024 | — | Argus Research | — | Upgrade | Hold → Buy | |||
02/26/2024 | 4.78% | Leerink Partners | → $260 | Initiates | → Outperform | |||
02/09/2024 | -3.28% | Evercore ISI Group | → $240 | Initiates | → In-Line | |||
01/03/2024 | -10.53% | Barclays | → $222 | Initiates | → Equal-Weight | |||
11/17/2023 | 5.18% | JP Morgan | $259 → $261 | Maintains | Overweight | |||
10/31/2023 | -7.31% | Mizuho | $257 → $230 | Maintains | Buy | |||
09/21/2023 | -7.31% | B of A Securities | $238 → $230 | Maintains | Buy | |||
09/18/2023 | -4.49% | Baird | $251 → $237 | Maintains | Outperform | |||
09/15/2023 | 8.81% | Truist Securities | → $270 | Reiterates | Buy → Buy | |||
09/15/2023 | 3.57% | Mizuho | → $257 | Reiterates | Buy → Buy | |||
09/06/2023 | -15.37% | HSBC | → $210 | Initiates | → Hold | |||
08/14/2023 | 8.81% | Wells Fargo | $290 → $270 | Maintains | Overweight | |||
08/03/2023 | 4.78% | Morgan Stanley | $285 → $260 | Maintains | Overweight | |||
08/02/2023 | -6.91% | Credit Suisse | $247.41 → $231 | Maintains | Outperform | |||
07/31/2023 | 1.15% | Baird | $255 → $251 | Maintains | Outperform | |||
07/28/2023 | 8.81% | Truist Securities | $275 → $270 | Maintains | Buy | |||
06/05/2023 | 16.06% | Credit Suisse | → $288 | Reiterates | Outperform → Outperform | |||
05/16/2023 | 3.57% | Mizuho | $277 → $257 | Maintains | Buy | |||
05/10/2023 | 14.85% | Morgan Stanley | $295 → $285 | Maintains | Overweight | |||
05/01/2023 | 10.82% | Truist Securities | $285 → $275 | Maintains | Buy | |||
03/13/2023 | 16.06% | Credit Suisse | $304 → $288 | Maintains | Outperform | |||
02/21/2023 | 22.51% | Credit Suisse | $305 → $304 | Maintains | Outperform | |||
02/21/2023 | 16.87% | Wells Fargo | $315 → $290 | Maintains | Overweight | |||
02/17/2023 | 14.85% | Truist Securities | $275 → $285 | Maintains | Buy | |||
02/17/2023 | 4.78% | Citigroup | $250 → $260 | Maintains | Neutral | |||
02/17/2023 | 20.9% | Baird | $285 → $300 | Maintains | Outperform | |||
02/17/2023 | 11.63% | Mizuho | $250 → $277 | Maintains | Buy | |||
01/11/2023 | 14.85% | Baird | $270 → $285 | Maintains | Outperform | |||
01/06/2023 | 22.11% | Morgan Stanley | $290 → $303 | Maintains | Overweight | |||
12/12/2022 | 0.75% | Citigroup | → $250 | Downgrade | Buy → Neutral | |||
11/23/2022 | 22.91% | Credit Suisse | $308 → $305 | Maintains | Outperform | |||
11/03/2022 | 0.75% | Mizuho | $296 → $250 | Maintains | Buy | |||
10/31/2022 | 16.87% | Morgan Stanley | $300 → $290 | Maintains | Overweight |
FAQ
Quel est le cours indicatif de l'action Labcorp Hldgs (LH) ?
Le dernier objectif de prix pour Labcorp Hldgs (NYSE:LH) a été rapporté par UBS le octobre 29, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $320.00 s'attendant à ce que LH se rise dans les 12 prochains mois (un possible changement de 28.96% upside). 31 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour Labcorp Hldgs (LH) ?
La dernière note d'analyste pour Labcorp Hldgs (NYSE:LH) a été fournie par UBS, et Labcorp Hldgs maintenu leur note buy.
Quand a eu lieu la dernière mise à niveau pour Labcorp Hldgs (LH) ?
La dernière amélioration pour Labcorp Holdings Inc a eu lieu le mars 4, 2025 lorsque Citigroup a augmenté leur objectif de prix à $300. Citigroup avait précédemment a neutral pour Labcorp Holdings Inc.
Quand a eu lieu la dernière dégradation pour Labcorp Hldgs (LH) ?
La dernière réduction pour Labcorp Holdings Inc a eu lieu le décembre 12, 2022 lorsque Citigroup a changé leur objectif de prix de N/A à $250 pour Labcorp Holdings Inc.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour Labcorp Hldgs (LH) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Labcorp Hldgs, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Labcorp Hldgs a été déposée le octobre 29, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 29, 2026.
La note d'analyste pour Labcorp Hldgs (LH) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de Labcorp Hldgs (LH) était un maintenu avec un objectif de prix de $325.00 à $320.00. Le prix actuel de Labcorp Hldgs (LH) est de $248.14, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.